Evidence map›Paper›PMID 31905900›Full record

ArticleMolecules (Basel, Switzerland)2019

Design of Iodonium Salts for UV or Near-UV LEDs for Photoacid Generator and Polymerization Purposes.

Ségolène Villotte, Didier Gigmes, Frédéric Dumur, Jacques Lalevée

Abstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Recent Advances inMolecules (Basel, Switzerland) · 2021
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Ségolène VillotteAix Marseille Univ, CNRS, ICR UMR 7273, 13397 Marseille, France.
Didier GigmesAix Marseille Univ, CNRS, ICR UMR 7273, 13397 Marseille, France.ORCID 0000-0002-8833-8393
Frédéric DumurAix Marseille Univ, CNRS, ICR UMR 7273, 13397 Marseille, France.ORCID 0000-0003-4872-094X
Jacques LalevéeUniversité de Haute-Alsace, CNRS, IS2M UMR 7361, F-68100 Mulhouse, France.ORCID 0000-0001-9297-0335

Funding

Conseil Régional d'Alsace MIPPI 4DGrand ESt MIPPI4DRegion Grand Est Mippi 4DRegion Grand Est Mippi4Dundefined <span style="color:gray;font-size:10px;">undefined</span> Mippi-4D
6 · The paper itself

Abstract

Iodonium salts are well established photoacid generators, cationic photoinitiators, as well as additives commonly used in photoredox catalytic cycles. However, as a strong limitation, iodonium salts are characterized by low light absorption properties for λ > 300 nm so that these latter cannot be activated with cheap, safe, and eco-friendly near UV or even visible light emitting diodes (LEDs). To overcome this drawback, the covalent linkage of an iodonium salt to a chromophore absorbing at longer wavelength is actively researched. With aim at red-shifting the absorption spectrum of the iodonium salt, the synthesis of new compounds combining within a unique chemical structure both the chromophore (here the naphthalimide scaffold) and the iodonium salt is presented. By mean of this strategy, a polymerization could be initiated at 365 nm with the modified iodonium salts whereas no polymerization could be induced with the benchmark iodonium salt i.e., Speedcure 938 at this specific wavelength. To examine the effect of the counter-anion on the photoinitiating ability of these different salts, five different counter-anions were used. Comparison between the different anions revealed the

Indexed as

CatalysisOnium CompoundsPhotochemical ProcessesPolymerizationPolymersSaltsUltraviolet RaysOnium CompoundsPolymersSaltscationic initiatoriodonium saltLEDphotoacidphotopolymerization

Identifiers

PMID31905900
PMCPMC6982746

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.